A groundbreaking retinal implant called PRIMA has enabled blind patients with dry AMD to read again. The chip, powered by ...
Presenters at the AAO discussed phase 2 clinical trial results evaluating the safety and efficacy of foselutoclax (UBX1325) compared with aflibercept in diabetic macular edema.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback